Paper39593161
Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.
Chernosky NM and 5 others. Breast Cancer Res, 2024. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program. Papers, record 39593161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39593161
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.
- PubMed
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Oncostatin M | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Interferon-beta | Major topic |
| Toll-Like Receptor 3 | Major topic |
| Triple Negative Breast Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Humans | |
| Cell Line, Tumor | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Signal Transduction | |
| Zinc Finger E-box-Binding Homeobox 1 | |
| Cell Movement |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| S10 OD024981 | NIH HHS | United States | S10OD024981 | PubMed | NIH RePORTER |
| R01CA252224 | NIH HHS | United States | R01CA252224 | PubMed and NIH | NIH RePORTER |
| P01 CA272161 | NCI NIH HHS | United States | P01CA272161 | PubMed | NIH RePORTER |
| R01 CA252224 | NCI NIH HHS | United States | R01CA252224 | PubMed and NIH | NIH RePORTER |
| W81XWH-20-1-0464; BC191534 | US Department of Defense Breast Cancer Research Program | PubMed | PubMed | ||
| P30 DK097948 | NIDDK NIH HHS | United States | P30DK097948 | PubMed | NIH RePORTER |
| P30 CA043703 | NCI NIH HHS | United States | P30CA043703 | PubMed | NIH RePORTER |
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24434209 | Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. | Cancer Cell | 2014 | https://conductscience.org/library/papers/24434209 | PubMed |
| 2 | 24398568 | High efficiency cell-specific targeting of cytokine activity. | Nat Commun | 2014 | https://conductscience.org/library/papers/24398568 | PubMed |
| 3 | 24652403 | Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. | Cancer Immunol Immunother | 2014 | https://conductscience.org/library/papers/24652403 | PubMed |
| 4 | 30190477 | LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. | Nat Commun | 2018 | https://conductscience.org/library/papers/30190477 | PubMed |
| 5 | 36876871 | cGAS-STING signalling in cancer: striking a balance with chromosomal instability. | Biochem Soc Trans | 2023 | https://conductscience.org/library/papers/36876871 | PubMed |
| 6 | 31036052 | The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/31036052 | PubMed |
| 7 | 15733829 | Transcriptional signaling by double-stranded RNA: role of TLR3. | Cytokine Growth Factor Rev | 2005 | https://conductscience.org/library/papers/15733829 | PubMed |
| 8 | 16757721 | Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. | JAMA | 2006 | https://conductscience.org/library/papers/16757721 | PubMed |
| 9 | 25453096 | Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25453096 | PubMed |
| 10 | 22328912 | Interferon-stimulated genes and their antiviral effector functions. | Curr Opin Virol | 2011 | https://conductscience.org/library/papers/22328912 | PubMed |
| 11 | 37333017 | Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy. | Front Mol Biosci | 2023 | https://conductscience.org/library/papers/37333017 | PubMed |
| 12 | 25344738 | Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. | Nat Med | 2014 | https://conductscience.org/library/papers/25344738 | PubMed |
| 13 | 34414698 | Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses. | J Zhejiang Univ Sci B | 2021 | https://conductscience.org/library/papers/34414698 | PubMed |
| 14 | 30450098 | Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation. | Front Immunol | 2018 | https://conductscience.org/library/papers/30450098 | PubMed |
| 15 | 32477956 | Pharmacological STING Activation Is a Potential Alternative to Overcome Drug-Resistance in Melanoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/32477956 | PubMed |
| 16 | 19567251 | ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. | J Immunol Methods | 2009 | https://conductscience.org/library/papers/19567251 | PubMed |
| 17 | 31564637 | An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer. | Cancer Cell | 2019 | https://conductscience.org/library/papers/31564637 | PubMed |
| 18 | 35192545 | Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35192545 | PubMed |
| 19 | 25430879 | Type I IFN gene delivery suppresses regulatory T cells within tumors. | Cancer Gene Ther | 2014 | https://conductscience.org/library/papers/25430879 | PubMed |
| 20 | 28848054 | Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28848054 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40868199 | Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868199 |
Source PubMed
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 | NCBI Gene |
| OSM | 5008 | PubTator's text mining | https://conductscience.org/library/genes/5008 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TLR3 | 7098 | PubTator's text mining | https://conductscience.org/library/genes/7098 | NCBI Gene |
| ZEB1 | 6935 | PubTator's text mining | https://conductscience.org/library/genes/6935 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39593161
GET https://conductscience.org/api/papers/v1/39593161/references?page=2